health

Patent protections on new drugs have unleashed an unprecedented wave of innovation that has benefited patients and should be fiercely guarded, according to a new study published by Pioneer Institute. New research indicates that price controls contained in the Inflation Reduction Act will result in 230 fewer drugs coming to market over the next decade and job losses of between 730,000 and 1.1 million.

A 2019 federal law requires hospitals to make prices for 300 shoppable services available online in a “consumer-friendly format,” but a Pioneer Institute survey of 19 hospitals finds that information on discounted cash prices—the price most likely to be charged to consumers paying out of pocket—was unavailable at seven of those hospitals.

Massachusetts’ emergency declaration for COVID-19 ends on June 15, and with it some enhanced flexibility that has been allowed in the healthcare system.  Some of the added flexibility highlighted barriers that make the system more expensive, harder to access and less patient-centered, and the Commonwealth should consider permanently removing these barriers, according to a new study published by Pioneer Institute.

Great strides have been made to increase healthcare price transparency through online cost estimator tools and a state law that requires providers to give out price information. Yet despite the eagerness of consumers to access prices and out-of-pocket costs, many are unaware that such information is available and don’t know how to access it, according to survey results published by Pioneer Institute.

In June 2019, Pioneer Institute, with support from Blue Cross Blue Shield of Massachusetts and the Massachusetts Association of Health Plans, contracted with noted pollster David Paleologos, head of DAPA Research at Suffolk University’s Research Bureau, to conduct a valid and reliable survey of Massachusetts consumers with employer sponsored health insurance. The goals of the survey were to determine consumers’ awareness, attitudes, views, usage, and knowledge of healthcare prices. This white paper presents analysis of the results.

In 2016, the rate of opioid overdose deaths in Massachusetts was more than double the national average (29.7 compared to 13.3 per 100,000 people). But Massachusetts doesn’t follow the usual trend for its users. Other states (like Alabama, Kentucky, and West Virginia)...

BOSTON - New policy briefs from Josh Archambault and Barbara Anthony, two senior fellows in healthcare at Pioneer Institute, offer differing prescriptions for how Massachusetts should navigate uncertainty in the healthcare market, as Congress debates the fate of the federal Affordable Care Act (ACA).

Wide variation found in price of generics, less for brand-name drugs; consumers must navigate difficult terrain to find lowest price BOSTON – It’s far easier to get prescription drug price information than to get similar numbers from hospitals or specialty physicians, but...

Read this op-ed in the Boston Herald (September 4, 2016). Sometimes the Affordable Care Act (ACA) seems like part of history. While headlines about implementation pains persist, many changes are taking place under the radar. One such change that has received almost no...

In Part 3 of Pioneer Institute’s series on Massachusetts’ Payment Reform legislation, Health Care Policy Director Josh Archambault asks important questions about the broad power given to new bureaucracies, and the costs.